Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration
Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (December 2023)